Frontal delta-beta cross-frequency coupling in high and low social anxiety: An index of stress regulation?

Cognitive, Affective & Behavioral Neuroscience
Eefje S PoppelaarsMelle J W van der Molen

Abstract

Cross-frequency coupling (CFC) between frontal delta (1-4 Hz) and beta (14-30 Hz) oscillations has been suggested as a candidate neural correlate of social anxiety disorder, a disorder characterized by fear and avoidance of social and performance situations. Prior studies have used amplitude-amplitude correlation (AAC) as a CFC measure and hypothesized it as a candidate neural mechanism of affective control. However, using this metric has yielded inconsistent results regarding the direction of CFC, and the functional significance of coupling strength is uncertain. To offer a better understanding of CFC in social anxiety, we compared frontal delta-beta AAC with phase-amplitude coupling (PAC) - a mechanism for information transfer through neural circuits. Twenty high socially anxious (HSA) and 32 low socially anxious (LSA) female undergraduates participated in a social performance task (SPT). Delta-beta PAC and AAC were estimated during the resting state, as well as the anticipation and recovery conditions. Results showed significantly more AAC in LSA than HSA participants during early anticipation, as well as significant values during all conditions in LSA participants only. PAC did not distinguish between LSA and HSA participan...Continue Reading

References

Aug 1, 1991·Electroencephalography and Clinical Neurophysiology·F Lopes da Silva
Jan 1, 1987·Modern Problems of Pharmacopsychiatry·M R Liebowitz
Dec 1, 1996·Journal of Personality Assessment·A T BeckW Ranieri
Jul 8, 1998·Journal of Anxiety Disorders·C L TurkM R Liebowitz
Oct 31, 2002·Journal of Anxiety Disorders·Douglas S MenninMichael R Liebowitz
Jun 26, 2004·Science·György Buzsáki, Andreas Draguhn
Mar 3, 2005·Biological Psychology·Brigitte M Kudielka, Clemens Kirschbaum
Dec 24, 2005·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Dennis J L G SchutterJack van Honk
Mar 7, 2006·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Gennady G KnyazevJack van Honk
Mar 28, 2006·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Erol Başar
May 12, 2006·Depression and Anxiety·R Nicholas CarletonGordon J G Asmundson
Dec 6, 2006·Neuroscience and Biobehavioral Reviews·Gennady G Knyazev
May 23, 2007·Journal of Neuroscience Methods·Eric Maris, Robert Oostenveld
Jun 6, 2007·Trends in Cognitive Sciences·Ole Jensen, Laura L Colgin
Sep 22, 2007·Journal of Anxiety Disorders·Justin W WeeksThomas L Rodebaugh
Oct 4, 2007·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Robert J BarryJacqueline A Rushby
Mar 11, 2008·Journal of Neuroscience Methods·Mark A KramerNancy J Kopell
May 31, 2008·Journal of Cognitive Neuroscience·Michael X CohenJuergen Fell
Aug 5, 2008·Journal of Neuroscience Methods·W D PennyJ G Ojemann
Nov 6, 2008·Social Cognitive and Affective Neuroscience·Sarah J BanksK Luan Phan
Jan 16, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Felix DarvasJeffrey G Ojemann
Jun 25, 2009·Progress in Neurobiology·Calvin K Young, Jos J Eggermont
Apr 3, 2010·Current Opinion in Neurobiology·Andreas K Engel, Pascal Fries
Aug 10, 2010·Neuroscience Letters·Bahar Güntekin, Erol Başar
Oct 12, 2010·Trends in Cognitive Sciences·Ryan T Canolty, Robert T Knight
Nov 10, 2010·Frontiers in Human Neuroscience·Bradley VoytekRobert T Knight
Feb 1, 2011·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Peter Putman
Apr 5, 2011·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Gennady G Knyazev
Nov 1, 2011·Annual Review of Clinical Psychology·Susan Nolen-Hoeksema
Jan 6, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Roemer van der MeijEric Maris
Jan 12, 2012·Nature Reviews. Neuroscience·Markus SiegelAndreas K Engel
Feb 23, 2012·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Peter PutmanCharlotte van Schie
Mar 27, 2012·Motivation and Emotion·Dennis J L G Schutter, Gennady G Knyazev
Jan 23, 2014·Journal of Neuroscience Methods·Dino Dvorak, André A Fenton
Aug 12, 2014·Brain Connectivity·Jeffrey I BermanJ Christopher Edgar
Sep 13, 2014·Current Opinion in Neurobiology·Juhan AruRaul Vicente
Dec 17, 2014·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Roy CoxLucia M Talamini
Aug 2, 2015·Journal of Neuroscience Methods·Joram van DrielMichael X Cohen
Jun 1, 2016·Biological cybernetics·Mojtaba ChehelcheraghiCees van Leeuwen
Oct 30, 2016·Social Cognitive and Affective Neuroscience·Suzanne N Avery, Jennifer Urbano Blackford

❮ Previous
Next ❯

Citations

Feb 28, 2019·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Kristie L Poole, Louis A Schmidt
May 22, 2020·Personality Neuroscience·Satish JaiswalWei-Kuang Liang
Jun 9, 2020·Frontiers in Psychology·Abdulhakim Al-EzziEsther Gunaseli
Apr 10, 2021·Frontiers in Human Neuroscience·Ismael Palacios-GarcíaConrado A Bosman
May 24, 2021·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Vanessa D Ruiz-StovelGeisa B Gallardo-Moreno

❮ Previous
Next ❯

Software Mentioned

SPSS
MATLAB
BVA
Brain Vision Analyzer ( BVA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.